303 related articles for article (PubMed ID: 33498631)
1. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro.
Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Blandizzi C; Brun P; Castagliuolo I
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498631
[TBL] [Abstract][Full Text] [Related]
2.
Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Brun P; Castagliuolo I
Gut Microbes; 2021; 13(1):1961970. PubMed ID: 34365895
[TBL] [Abstract][Full Text] [Related]
3. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
Mirabelli C; Wotring JW; Zhang CJ; McCarty SM; Fursmidt R; Pretto CD; Qiao Y; Zhang Y; Frum T; Kadambi NS; Amin AT; O'Meara TR; Spence JR; Huang J; Alysandratos KD; Kotton DN; Handelman SK; Wobus CE; Weatherwax KJ; Mashour GA; O'Meara MJ; Chinnaiyan AM; Sexton JZ
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34413211
[TBL] [Abstract][Full Text] [Related]
4. The
Hu Y; Meng X; Zhang F; Xiang Y; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):317-330. PubMed ID: 33560940
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
Chang R; Ng TB; Sun WZ
Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
[TBL] [Abstract][Full Text] [Related]
6. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.
Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P
Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.
Maestro S; Córdoba KM; Olague C; Argemi J; Ávila MA; González-Aseguinolaza G; Smerdou C; Fontanellas A
Biomed Pharmacother; 2021 May; 137():111384. PubMed ID: 33761605
[TBL] [Abstract][Full Text] [Related]
8. Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.
Alexander MR; Brice AM; Jansen van Vuren P; Rootes CL; Tribolet L; Cowled C; Bean AGD; Stewart CR
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806254
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin Against SARS-CoV-2:
Campione E; Lanna C; Cosio T; Rosa L; Conte MP; Iacovelli F; Romeo A; Falconi M; Del Vecchio C; Franchin E; Lia MS; Minieri M; Chiaramonte C; Ciotti M; Nuccetelli M; Terrinoni A; Iannuzzi I; Coppeda L; Magrini A; Bernardini S; Sabatini S; Rosapepe F; Bartoletti PL; Moricca N; Di Lorenzo A; Andreoni M; Sarmati L; Miani A; Piscitelli P; Valenti P; Bianchi L
Front Pharmacol; 2021; 12():666600. PubMed ID: 34220505
[TBL] [Abstract][Full Text] [Related]
10. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats.
El-Fakharany EM; El-Gendi H; El-Maradny YA; Abu-Serie MM; Abdel-Wahhab KG; Shabana ME; Ashry M
Int J Biol Macromol; 2023 Aug; 245():125552. PubMed ID: 37356684
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2.
Gendrot M; Andreani J; Jardot P; Hutter S; Delandre O; Boxberger M; Mosnier J; Le Bideau M; Duflot I; Fonta I; Rolland C; Bogreau H; La Scola B; Pradines B
Molecules; 2020 Oct; 25(21):. PubMed ID: 33142770
[TBL] [Abstract][Full Text] [Related]
13. Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro.
Andreu S; Ripa I; Bello-Morales R; López-Guerrero JA
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112952
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Flórez-Álvarez L; Yepes LM; Rugeles MT; Zapata-Builes W; Hernandez JC; Taborda NA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833991
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19.
Gaziano R; Pistoia ES; Campione E; Fontana C; Marino D; Favaro M; Pica F; Di Francesco P
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4174-4184. PubMed ID: 34156699
[TBL] [Abstract][Full Text] [Related]
16. Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro.
Kobayashi-Sakamoto M; Maeda T; Kimura M; Yusa J; Ito H; Tani H; Kato Y; Hirose K
Biochem Cell Biol; 2022 Aug; 100(4):338-348. PubMed ID: 35830725
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study.
Rosa L; Tripepi G; Naldi E; Aimati M; Santangeli S; Venditto F; Caldarelli M; Valenti P
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575388
[TBL] [Abstract][Full Text] [Related]
18. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
Runfeng L; Yunlong H; Jicheng H; Weiqi P; Qinhai M; Yongxia S; Chufang L; Jin Z; Zhenhua J; Haiming J; Kui Z; Shuxiang H; Jun D; Xiaobo L; Xiaotao H; Lin W; Nanshan Z; Zifeng Y
Pharmacol Res; 2020 Jun; 156():104761. PubMed ID: 32205232
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
[TBL] [Abstract][Full Text] [Related]
20. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
